Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
STLN · against 1,216 other Healthcare companies
Ranked #251 of 1,217 · scores higher than 79% of peers
Bars: peers in each 10-point band of the growth score121 peers with a growth score of 70–79, including STLN · Click a bar to see the companies
Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | STLN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 38.4% | 6.1% | 88% | 33% | |
| Earnings per share growthHigher is better · 682 reported | -14.0% | 9.7% | 27% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 26.1% | 5.8% | 86% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 251 | 3.9B SEK (≈$385M) | 79 | 23 | |
| 251 | 1.5B USD | 79 | 43 | |
| 251 | 1.8B BRL (≈$328M) | 79 | 65 | |
| 251 | 374M USD | 79 | 66 | |
| 251 | 646M USD | 79 | 46 | |
| 251 | 5.2B CHF (≈$5.9B) | 79 | 69 | |
| 263 | 200.2B KRW (≈$144M) | 78 | 62 | |
| 263 | 6.5B TWD (≈$200M) | 78 | 76 | |
| 263 | 1.8B USD | 78 | 63 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score